Vanos

— THERAPEUTIC CATEGORIES —
  • Topical steroids

Vanos Generic Name & Formulations

General Description

Fluocinonide 0.1%; crm.

Pharmacological Class

Steroid.

How Supplied

Crm—30g, 60g

Vanos Indications

Indications

Corticosteroid-responsive dermatoses.

Vanos Dosage and Administration

Adult

Do not use for >2 consecutive weeks. Apply thin film 1–2 times daily; max 60g/week.

Children

Not recommended.

Vanos Contraindications

Contraindications

Do not use superpotent forms on face, groin, or axillae. Exclude viral disease (eg, chickenpox, measles).

Vanos Boxed Warnings

Not Applicable

Vanos Warnings/Precautions

Warnings/Precautions

Treat infection if present; discontinue if infection persists or worsens. Do not use near eyes, or on diaper dermatitis or pre-existing skin atrophy. Do not use fluorinated steroids longer than 1 week on the face. Avoid abrupt cessation in chronic use. Systemic absorption increased by broken or inflamed skin, prolonged use, application to large surface area, or use of occlusive dressings. Occlude only if necessary; do not occlude higher potency products. Monitor adrenal function in children if a high potency product or occlusion is used, and in adults if more than 50g weekly of a high potency product is used. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, glucosuria, or irritation occurs. Use lowest effective dose and potency (esp. in children). Use caution if applying to face or body folds. Do not use continuously or for prophylaxis. Foams are flammable. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.

Vanos Pharmacokinetics

See Literature

Vanos Interactions

Not Applicable

Vanos Adverse Reactions

Adverse Reactions

Burning, stinging, pruritus, erythema, skin atrophy, striae, miliaria, secondary infections, hypopigmentation, folliculitis, hypertrichosis, acneiform eruptions, dermal cracking and fissuring, telangiectasia, contact dermatitis, other local effects, immunosuppression, masks infections, HPA axis suppression (esp. in children).

Vanos Clinical Trials

See Literature

Vanos Note

Not Applicable

Vanos Patient Counseling

See Literature